In the latter cells, lenalidomide inhibits the paracrine production of BAFF and APRIL.68 Thus, as with bortezomib, there is evidence that at least part of the anti-myeloma effect of IMiDs may be attributed to the inhibition of BAFF/APRIL signaling. The gene discussed is TNFSF13; the disease is plasma cell myeloma.